<DOC>
	<DOCNO>NCT02061917</DOCNO>
	<brief_summary>To evaluate select biomarkers tobacco exposure biomarkers harm ass quality life measure smoker randomly switch usual brand cigarette one three test product : ( 1 ) tobacco-heating cigarette ; ( 2 ) snus ( smokeless tobacco ) ; ( 3 ) ultra-low machine yield tobacco-burning cigarette .</brief_summary>
	<brief_title>Switching From Usual Brand Cigarettes Tobacco-heating Cigarette Snus</brief_title>
	<detailed_description>A randomized , multi-center , 4-group study health status measure biomarkers subject smoke switch either tobacco-heating cigarette , snus , tobacco-burning cigarette , non-treatment group never-smokers . Primary Objectives : - Evaluate select biomarkers tobacco exposure biomarkers harm subject smoke switched tobacco-heating cigarette , snus , tobacco-burning cigarette . - Evaluate ability tobacco-heating cigarette snus modify patient-reported Chronic Obstructive Pulmonary Disease ( COPD ) -related health status subject smoke switch either tobacco-heating cigarette snus relative control group ( tobacco-burning ultra-low machine yield [ ULMY ] ) cigarette . - Assess subject compliance . Secondary Objectives : - Measure amount repeatability smoke component yield cigarette ( yield use ) determine relative uptake select smoke component . - Evaluate ability tobacco-heating cigarette snus modify general health status measure self-administered health questionnaire subject smoke switch either tobacco-heating cigarette snus relative control group ( tobacco-burning ULMY cigarette ) . - Compare health status measure smoker switch tobacco-heating cigarette smoker switch snus . - Compare baseline data tobacco-using group baseline data never-smoking ( non-treatment ) group .</detailed_description>
	<mesh_term>Lobeline</mesh_term>
	<criteria>Males female , 28 55 year age , inclusive . Cigaretteonly smoker currently smoke least 15 cigarette daily smoke least 10 year prior Week 0 ( i.e. , chronic cigarette smoker ) . Smokers intend quit smoking , willing switch tobacco product ( intent quit define intend make making quit attempt within 1 month prior Week 0 ) . Nonsmoking subject selfreported `` NeverSmoker '' per American Thoracic Society Questionnaire definition , urinary cotinine level exceed 50 ng/mL . Subjects , opinion Investigators , free clinically significant health problem medication daily basis chronic medical disorder deem clinically significant Investigator ( ) . Subjects regularly take creatine supplement . Subjects test negative select drug abuse Screening ( include alcohol test ) . Subjects negative hepatitis panel ( include hepatitis B surface antigen [ HBsAg ] hepatitis C virus antibody [ antiHCV ] ) negative Human Immunodeficiency Virus ( HIV ) antibody screen ( subject immunize hepatitis B documentation immunization , positive test result exclusionary ) . Female subject nonpregnant ( urine pregnancy test result negative Screening Weeks 0 , 12 , 24 ) , nonlactating , either postmenopausal ( verified Follicle Stimulating Hormone level ) least 1 year , surgically sterile ( e.g. , tubal ligation , hysterectomy ) least 90 day , agree use time signing inform consent 30 day Week 24 ( Study Completion ) form contraception consider acceptable Investigators ( oral , injectable implantable contraceptive , intrauterine device barrier method ) . Subjects able read comprehend questionnaire English willing sign Informed Consent Form . Smokers use tobacco nicotinecontaining product device tobaccoburning cigarette 6 month prior study Week 24 , include cigar , pipe , chew tobacco , snuff , snus , nicotine patch , nicotine gum , etc . A history clinical manifestation significant metabolic , hepatic , renal , hematological , pulmonary , cardiovascular , gastrointestinal , urological , neurological , psychiatric disorder . A history hypersensitivity allergy drug compound unless approve Investigator ( ) . A history presence abnormal ECG deem clinically significant Investigator . A history alcoholism drug addiction within 1 year prior Study Entry . Evidence visible oral cancer , find oral health examination base oral health question visit . Any acute chronic condition , Investigator ( ) ' opinion , limit subject 's ability complete and/or participate study . Donation blood 30 day prior Screening Week 24 ( Study Completion ) , inclusive , plasma 2 week prior Screening Week 24 ( Study Completion ) , inclusive . Receipt blood product within 2 month prior Study Entry . Subject relative subject currently ever employ tobacco industry . Subject participate investigational study drug product trial receipt investigational study drug product occur within 30 day prior Checkin ( inclusive ) .</criteria>
	<gender>All</gender>
	<minimum_age>28 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Biomarkers</keyword>
	<keyword>Tobacco</keyword>
	<keyword>Tobacco-heating</keyword>
	<keyword>Smokeless Tobacco</keyword>
	<keyword>Snus</keyword>
	<keyword>Smoking</keyword>
	<keyword>Exposure</keyword>
	<keyword>Quality Life</keyword>
</DOC>